Sovihep D is manufactured by Zyduss.
Sovihep D is available in tablets form.
Sovihep D contains daclatasvir 60 mg & Sofosbovir 400 mg.
Daclatasvir is used with another antiviral medication (sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Daclatasvir should never be used without sofosbuvir. Daclatasvir and sofosbuvir may also be used with another antiviral medication (ribavirin).
Sofosbuvir, sold under the brand name Sovaldi among others, is a medication used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir, daclatasvir, or velpatasvir
Daclatasvir/sofosbuvir is a two-drug combination for the treatment of hepatitis C. It is given as a single daily pill containing daclatasvir, the viral NS5A inhibitor and sofosbuvir, a nucleotide inhibitor of the viral RNA polymerase.
Sovihep D tablets is a New Drug Combo Helps Hard to Treat Hepatitis C
Consolidating an old medication with a trial one may fix numerous instances of difficult-to-treat hepatitis C without the unforgiving symptoms of the standard regimen.
Warning: Keep Sovihep D medicine out of the reach and sight of children and away from pets, never share your medicines with others, and use this medication only for the indication prescribed. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.